Groupama Asset Managment »

Bio-Rad Laboratories shares owned by Groupama Asset Managment

Quarter-by-quarter ownership of Bio-Rad Laboratories (BIO) shares owned by Groupama Asset Managment from 13F filings

Historical chart of Groupama Asset Managment investment in Bio-Rad Laboratories

Tip: Access up to 7 years of quarterly data

All positions including Bio-Rad Laboratories held by Groupama Asset Managment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bio-Rad Laboratories by Groupama Asset Managment

Quarter filed Position value Share count Share price at filing
2023-12-31 $685k 2.1k 322.99

More positions owned by Groupama Asset Managment

Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Amazon (AMZN)
UnitedHealth (UNH)
NVIDIA Corporation (NVDA)
Motorola Solutions Com New (MSI)
Merck & Co (MRK)
JPMorgan Chase & Co. (JPM)
Micron Technology (MU)
Parker-Hannifin Corporation (PH)
Thermo Fisher Scientific (TMO)
Regeneron Pharmaceuticals (REGN)
Tesla Motors (TSLA)

View all positions for Groupama Asset Managment

Top funds holding Bio-Rad Laboratories

Vanguard Group
BlackRock
Veritas Asset Management
Ubs Global Asset Management Americas
Alliancebernstein
Investec Asset Management
Earnest Partners
Bank of America Corporation
Southeastern Asset Management
Thompson, Siegel, & Walmsley
Massachusetts Financial Services
Dimensional Fund Advisors
Hound Partners
Parnassus Investments
Westfield Capital Management Company

View all funds holding Bio-Rad Laboratories